Summary
Plasma levels of temazepam were determined in healthy subjects after single oral administration of soft and hard gelatin capsules, and after 7 consecutive night-time doses in soft capsules. Absorption from soft gelatin capsules was significantly faster and produced earlier and higher peak plasma levels. The two pharmaceutical forms did not show any significant difference in relative availability. The apparent half-life of temazepam after night-time administration was significantly shorter than after morning administration, but no change in half-life was observed between the first and seventh night-time doses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Belvedere, G., Tognoni, G., Frigerio, A., Morselli, P.: A specific rapid and sensitive method for gas chromatographic determination of methyl-oxazepam in small samples of blood. Analyt. Lett.5, 531–541 (1972)
Borland, R. G., Nicholson, A. N.: Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance. Brit. J. clin. Pharmacol.2, 9–17 (1975)
Capaccio, A., Ambrosini, G., Veneri, F.: Valutazione controllata dell'attività di una nuova benzodiazepina, il temazepam, nelle sindromi ansiose ed ansioso-depressive di riscontro nella pratica tisiologica. Pneumologia9, 475–486 (1968)
Fargus, P. C. G., Hindmarch, I.: A 1,4 benzodiazepine, temazepam (ER 115): effect on reaction time during psychomotor behaviour related to car driving. IRCS Med. Sci.2, 1173 (1974)
Fuccella, L. M., Tosolini, G., Moro, E., Tamassia, V.: Study of physiological availability of temazepam in man. Int. J. clin. Pharmacol.64, 303–309 (1972)
Hindmarch, I.: Investigations of the behavioural effects of the benzodiazepines. Unpublished Research Seminar, Leeds (1974)
Hindmarch, I.: A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour. Arzneim. Forsch. (Drug Res.)25, 1836–1839 (1975)
Hindmarch, I.: A sub-chronic study of the subjective quality of sleep and psychological measures of performance on the morning following night time medication with temazepam. Arzneim. Forsch.26, 2113–2116 (1976)
Kaplan, S. A., de Silva, J. A. F., Jack, M. F., Alexander, K., Strojny, N., Weinfeld, R. E., Puglisi, C. V., Weissman, L.: Blood level profile in man following chronic oral administration of flurazepam hydrochloride. J. Pharm. Sci.62, 1932–1935 (1973)
Klotz, U., Antonin, K. H., Bieck, P. R.: Comparison of the pharmacokinetics of diazepam after single and subchronic doses. Europ. J. clin. Pharmacol.10, 121–126 (1976)
Linnoila, M., Saario, I., Maki, M.: Effect of treatment with diazepam or lithium and alcohol on psychomotor skills related to driving. Europ. J. clin. Pharmacol.7, 337–342 (1974)
Maccagnani, G., Ambrosini, G.: Sperimentazione clinica controllata di un nuovo derivato benzodiazepinico, il temazepam (ER 115) versus placebo, in terapia psichiatrica. Rass. Studi Psichiat.59, 33–58 (1970)
Maggini, C., Murri, L., Sacchetti, G.: Evaluation of the effectiveness of temazepam on the insomnia of patients with neurosis and endogenous depression. Arzneim. Forsch. (Drug Res.)19, 1647–1652 (1969)
Nicholson, A. N., Stone, B. M.: Effect of a metabolite of diazepam, 3-hydroxydiazepam (temazepam), on sleep in man. Brit. J. clin. Pharmacol.3, 543–550 (1976)
Nicholson, A. N., Stone, B. N., Clarke, C. H., Ferres, H. M.: Effect of N-desmethyldiazepam and a precursor, potassium chlorazepate, on sleep in man. Brit. J. clin. Pharmacol.3, 429–438 (1976)
Riccioni, R., Gallevi, M., Sacchetti, G., Castrogiovanni, P., Cassano, G. B.: Il temazepam: nuovo ansiolitico della serie 1–4 benzodiazepinica. Studio pilota nell'uomo. Neuropsichiatria34, 838–848 (1968)
Rieder, J., Gernot, W.: Pharmacokinetics and metabolism of the hypnotic nitrazepam. In “The Benzodiazepines” (ed. Garattini, S., Mussini, E. & Randall, L. O.), p. 99. New York: Raven Press 1973
Sarteschi, P., Cassano, G. B., Castrogiovanni, P., Placidi, G. F., Sacchetti, G.: Major and minor transquillizers in the treatment of anxiety states. Arzneim. Forsch. (Drug Res.)22, 93–97 (1972)
Tansella, M., Siciliani, O., Burti, L., Schiavon, M., Zimmermann Tansella, C. H., Gerna, M., Tognoni, G., Morselli, P. L.: N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia (Berl.)41, 81–85 (1975)
Tansella, M., Zimmermann Tansella, C. H., Lader, M.: The residual effects of N-desmethyldiazepam in patients. Psychopharmacologia (Berl.)38, 81–90 (1974)
Tognoni, G., Gomeni, R., De Maio, D., Alberti, G. G., Franciosi, P., Scieghi, G.: Pharmacokinetics of N-desmethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Brit. J. clin. Pharmacol.2, 227–232, 1975.
Wagner, J. G. Fundamental of clinical pharmacokinetics, p. 461. Hamilton, IL: Drug Intelligence Publications 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuccella, L.M., Bolcioni, G., Tamassia, V. et al. Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol 12, 383–386 (1977). https://doi.org/10.1007/BF00562455
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00562455